Vuong Trieu - CHAIRMAN AND CEO, Director, 10%+ Owner at Oncotelic Therapeutics, Inc.

Issuer-level insider activity

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Issuer ticker
OTLC on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Vuong Trieu in Oncotelic Therapeutics, Inc.

Buys

Open market
Shares
+830,759
Avg price
$0.0443
Total value
+$36,832

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+830,759
Share %
100%
Total value
+$36,832

Reported holdings for Vuong Trieu in Oncotelic Therapeutics, Inc.

Form 4 holding CHAIRMAN AND CEO, Director, 10%+ Owner

Oncotelic Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
8,491
Estimated value
Report date
22 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHAIRMAN AND CEO, Director, 10%+ Owner

Oncotelic Therapeutics, Inc.

Security class
Restricted stock Units
Shares / value
2,000
Estimated value
Report date
10 Jul 2026
Price
Ownership
Direct
Underlying class
Series A Preferred Stock
Underlying amount

Transaction history for Vuong Trieu in Oncotelic Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .